MediciNova Statistics
Total Valuation
MediciNova has a market cap or net worth of $59.84 million. The enterprise value is $26.86 million.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MediciNova has 49.05 million shares outstanding.
| Current Share Class | 49.05M |
| Shares Outstanding | 49.05M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.98% |
| Owned by Institutions (%) | 10.57% |
| Float | 42.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 451.84 |
| Forward PS | n/a |
| PB Ratio | 1.30 |
| P/TBV Ratio | 1.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 199.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.26, with a Debt / Equity ratio of 0.01.
| Current Ratio | 13.26 |
| Quick Ratio | 12.99 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -22.66% and return on invested capital (ROIC) is -15.83%.
| Return on Equity (ROE) | -22.66% |
| Return on Assets (ROA) | -15.09% |
| Return on Invested Capital (ROIC) | -15.83% |
| Return on Capital Employed (ROCE) | -28.20% |
| Revenue Per Employee | $10,354 |
| Profits Per Employee | -$908,626 |
| Employee Count | 13 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MediciNova has paid $5,537 in taxes.
| Income Tax | 5,537 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.42% in the last 52 weeks. The beta is 0.43, so MediciNova's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -32.42% |
| 50-Day Moving Average | 1.30 |
| 200-Day Moving Average | 1.58 |
| Relative Strength Index (RSI) | 40.03 |
| Average Volume (20 Days) | 64,647 |
Short Selling Information
The latest short interest is 148,133, so 0.30% of the outstanding shares have been sold short.
| Short Interest | 148,133 |
| Short Previous Month | 125,656 |
| Short % of Shares Out | 0.30% |
| Short % of Float | 0.35% |
| Short Ratio (days to cover) | 2.31 |
Income Statement
In the last 12 months, MediciNova had revenue of $134,599 and -$11.81 million in losses. Loss per share was -$0.24.
| Revenue | 134,599 |
| Gross Profit | 18,250 |
| Operating Income | -13.30M |
| Pretax Income | -8.16M |
| Net Income | -11.81M |
| EBITDA | -13.28M |
| EBIT | -13.30M |
| Loss Per Share | -$0.24 |
Full Income StatementBalance Sheet
The company has $34.26 million in cash and $301,880 in debt, giving a net cash position of $33.96 million or $0.69 per share.
| Cash & Cash Equivalents | 34.26M |
| Total Debt | 301,880 |
| Net Cash | 33.96M |
| Net Cash Per Share | $0.69 |
| Equity (Book Value) | 46.86M |
| Book Value Per Share | 0.96 |
| Working Capital | 32.48M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.05 million and capital expenditures -$4, giving a free cash flow of -$10.05 million.
| Operating Cash Flow | -10.05M |
| Capital Expenditures | -4 |
| Free Cash Flow | -10.05M |
| FCF Per Share | -$0.20 |
Full Cash Flow StatementMargins
| Gross Margin | 13.56% |
| Operating Margin | -9,883.02% |
| Pretax Margin | -8,771.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MediciNova does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -19.42% |
| FCF Yield | -16.53% |
Analyst Forecast
The average price target for MediciNova is $7.00, which is 473.77% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 473.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -22.94% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MediciNova has an Altman Z-Score of 4.11 and a Piotroski F-Score of 1.
| Altman Z-Score | 4.11 |
| Piotroski F-Score | 1 |
